Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes (Q68056499)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1992

edit

Language	Label	Description	Also known as
English	Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes	scientific article published on 01 January 1992

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

title

Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

author name string

C G Ioannides

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

B Fisk

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

B Tomasovic

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

R Pandita

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

B B Aggarwal

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

R S Freedman

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

publication date

1 January 1992

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

published in

Cancer Immunology, Immunotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

volume

35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

page(s)

83-91

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

cites work

The interleukin 2 receptor. Functional consequences of its bimolecular structure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibody

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OKT4 monoclonal antibody-induced activation of an autoreactive T-cell clone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interleukin 2 receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor alpha and interleukin 2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays, and as structural probes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human lymphotoxin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1534515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF01741854

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

PubMed publication ID

1534515

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1534515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1534515%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 September 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68056499&oldid=2218449944"